FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Search Results

Ketamine Injection
Status: Currently in Shortage
»Date first posted: 02/16/2018
»Therapeutic Categories: Anesthesia

Expand all

AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.) (Revised 04/01/2021)

Company Contact Information:
888-238-7880

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
200 mg / 20 mL (NDC 67457-181-20) Available; Check wholesalers for inventory Mylan label
500 mg / 10 mL (NDC 67457-001-10) Available; Check wholesalers for inventory Mylan label
1000 mg / 10 mL (NDC 67457-108-10) Available Mylan label; Check wholesalers for inventory

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Revised 04/08/2021)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
50 mg/mL, 10 mL vial (NDC 0143-9508-10) This presentation is temporarily on backorder. Additional lots are scheduled to be manufactured and available in the April - May 2021 timeframe. Product will be made available as it is released. Demand increase for the drug
100 mg/mL, 5 mL vial (NDC 0143-9509-10) Inventory is currently available. Additional lots are scheduled to be manufactured. Product will be made available as it is released.

Hospira, Inc. (Revised 04/08/2021)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500 mg/5 mL (100 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-2051-05) Limited Supply Available. Next Delivery: April 2021; Estimated Recovery: June 2021 Demand increase for the drug
500 mg/10 mL (50 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-2053-10) Next Delivery and Estimated Recovery: June 2021 Demand increase for the drug

Par Pharmaceutical (Revised 02/09/2021)

Company Contact Information:
201-802-4000

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10 mg/mL, 20 mL MDV (NDC 42023-113-10) Par Product Available – Please Check Wholesalers
100 mg/mL, 5 mL MDV (NDC 42023-115-10) Par Product Available – Please Check Wholesalers
50 mg/mL, 10 mL MDV (NDC 42023-114-10) Backordered. Expected recovery date is March 2021. Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English